feed,title,long_url,short_url
MedRxiv,Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously,https://medrxiv.org/cgi/content/short/2022.07.26.22278072v1?rss=1,https://bit.ly/3ze62Uu
